Individual dose adaptation of anticancer drugs
- 31 December 1994
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (6), 844-851
- https://doi.org/10.1016/0959-8049(94)90304-2
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- Pharmacokinetic Optimisation of Anticancer TherapyClinical Pharmacokinetics, 1991
- Pharmacokinetics of 5-Fluorouracil After Short Systemic InfusionTherapeutic Drug Monitoring, 1991
- Clinical Pharmacokinetics-Pharmacodynamicsof Anticancer DrugsClinical Pharmacokinetics, 1989
- Problems in the Use of Anticancer Drugs in The ElderlyDrugs, 1989
- Clinical and pharmacokinetic study of 96-h infusions of doxorubicin in advanced cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1989
- Therapeutic Drug Monitoring in OncologyClinical Pharmacokinetics, 1987
- Clinical Pharmacodynamics of High-Dose Methotrexate in Acute Lymphocytic LeukemiaNew England Journal of Medicine, 1986
- Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugsCancer Treatment Reviews, 1982
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977